A novel flow cytometric method for the quantification of p53 gene expression.

作者: Giuditta Filippini , Sayuri Griffin , Mario Uhr , Hans Eppenberger , Jos� Bonilla

DOI: 10.1002/(SICI)1097-0320(19980301)31:3<180::AID-CYTO5>3.0.CO;2-P

关键词:

摘要: We describe a rapid and simple flow cytometry technique for the detection quantification of p53 in several human cell lines, including an adenocarcinoma line (SW 626) having mutant (m) p53, pre-B leukemia (NALM-6) wild-type (wt) p53. By introducing second antibody coupled to RPE-fluorescence, discrimination between control specific peaks was improved over that achieved with methods used previously. To quantify content molecules cells, we series beads capability bind mouse monoclonal IgG antibodies. content, expressed as binding capacity (ABC), directly quantified from logarithmic scattergrams; results were reproducible all lines tested. Flow cytometric compared those standard immunocytochemistry method routinely found be correlation. Furthermore, data also reflect ELISA determinations. In summary, showed first time (i) can clearly detected by various (ii) quantitated terms number per cell, (iii) it easily monitored function after stimulation. Cytometry 31:180–186, 1998. © 1998 Wiley-Liss, Inc.

参考文章(18)
G Brandner, M Fritsche, C Haessler, Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. ,vol. 8, pp. 307- 318 ,(1993)
Jason E. Reynolds, Alan Eastman, Michael A. Barry, Etoposide-induced Apoptosis in Human HL-60 Cells Is Associated with Intracellular Acidification Cancer Research. ,vol. 53, pp. 2349- 2357 ,(1993)
Bert Vogelstein, David Sidransky, Ruth W. Craig, Michael B. Kastan, Onyinye Onyekwere, Participation of p53 Protein in the Cellular Response to DNA Damage Cancer Research. ,vol. 51, pp. 6304- 6311 ,(1991)
J. Pelletier, J. B. Beckwith, Nabeel Bardeesy, Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Research. ,vol. 55, pp. 215- 219 ,(1995)
R. K. Gupta, K. Patel, W. F. Bodmer, J. G. Bodmer, Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 2817- 2821 ,(1993) , 10.1073/PNAS.90.7.2817
John C. Law, Mary K. Ritke, Jack C. Yalowich, Gerd H. Leder, Robert E. Ferrell, Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line Leukemia Research. ,vol. 17, pp. 1045- 1050 ,(1993) , 10.1016/0145-2126(93)90161-D
David P. Lane, Worrying about p53. Current Biology. ,vol. 2, pp. 581- 583 ,(1992) , 10.1016/0960-9822(92)90154-3
M Hollstein, D Sidransky, B Vogelstein, C. Harris, p53 mutations in human cancers Science. ,vol. 253, pp. 49- 53 ,(1991) , 10.1126/SCIENCE.1905840
Richard Hurwitz, John Hozier, Tucker Lebien, Jun Minowada, Kazimiera Gajl-Peczalska, Ichiro Kubonishi, John Kersey, Characterization of a leukemic cell line of the pre‐B phenotype International Journal of Cancer. ,vol. 23, pp. 174- 180 ,(1979) , 10.1002/IJC.2910230206
G. Gaidano, P. Ballerini, J. Z. Gong, G. Inghirami, A. Neri, E. W. Newcomb, I. T. Magrath, D. M. Knowles, R. Dalla-Favera, p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 5413- 5417 ,(1991) , 10.1073/PNAS.88.12.5413